250737-16-7

Basic information

• Product Name: 3,4,6-tri-O-benzyl-2-[(benzyloxycarbonyl)amino]-5-dehydro-2-deoxy-5-hydroxy-D-glucono-δ-lactam
• Synonyms: 3,4,6-tri-O-benzyl-2-[(benzyloxycarbonyl)amino]-5-dehydro-2-deoxy-5-hydroxy-D-glucono-δ-lactam
• CAS NO: 250737-16-7
• Molecular Weight: 596.68
• Mol File: 250737-16-7.mol

Chemical Properties

• CAS DataBase Reference: 3,4,6-tri-O-benzyl-2-[(benzyloxycarbonyl)amino]-5-dehydro-2-deoxy-5-hydroxy-D-glucono-δ-lactam(CAS DataBase Reference)
• NIST Chemistry Reference: 3,4,6-tri-O-benzyl-2-[(benzyloxycarbonyl)amino]-5-dehydro-2-deoxy-5-hydroxy-D-glucono-δ-lactam(250737-16-7)
• EPA Substance Registry System: 3,4,6-tri-O-benzyl-2-[(benzyloxycarbonyl)amino]-5-dehydro-2-deoxy-5-hydroxy-D-glucono-δ-lactam(250737-16-7)

Safety Data

• Hazardous Substances Data: 250737-16-7(Hazardous Substances Data)

Downstream Products

• 250737-20-3 2-amino-3,4,6-tri-O-benzyl-2-deoxy-D-glucono-δ-lactam 
• 250737-22-5 2-amino-3,4,6-tri-O-benzyl-1,5-[(tert-butyloxycarbonyl)imino]-1,2,5-trideoxy-D-glucitol 
• 250737-19-0 3,4,6-tri-O-benzyl-2-[(benzyloxycarbonyl)amino]-1,2,5-trideoxy-1,5-imino-D-glucitol 
• 250737-21-4 3,4,6-tri-O-benzyl-2-[(benzyloxycarbonyl)amino]-1,5-[(tert-butyloxycarbonyl)imino]-1,2,5-trideoxy-D-glucitol 
• 250737-24-7 3,4,5-tri-O-benzyl-2-[(6-benzyloxycarbonyl)aminohexanoylamino]-deoxy-D-glucono-δ-lactam 
• 250737-26-9 3,4,5-tri-O-benzyl-2-[(6-benzyloxycarbonyl)aminohexanoylamino]-1,5-[(tert-butoxycarbonyl)imino]-1,2,5-trideoxy-D-glucitol 
• 250737-32-7 5-{3-[5-((3R,4R,5R,6R)-4,5-Dihydroxy-6-hydroxymethyl-2-oxo-piperidin-3-ylcarbamoyl)-pentylcarbamoyl]-4-nitro-phenyldisulfanyl}-2-nitro-benzoic acid 2,5-dioxo-pyrrolidin-1-yl ester 
• 250737-25-8 3,4,5-tri-O-benzyl-2-[(R)-3-(6-benzyloxycarbonyl)aminohexanoyloxytetradecanoylamino]-2-deoxy-D-glucono-δ-lactam 
• 250737-27-0 3,4,5-tri-O-benzyl-2-[(R)-3-(6-benzyloxycarbonyl)aminohexanoyloxytetradecanoylamino]-1,5-[(tert-butoxycarbonyl)imino]-1,2,5-trideoxy-D-glucitol 
• 250737-18-9 3,4,6-tri-O-benzyl-2-[(benzyloxycarbonyl)amino]-2-deoxy-D-glucono-δ-lactam 

Relevant articles and documents

Approach toward a generic treatment of gram-negative infections: Synthesis of haptens for catalytic antibody mediated cleavage of the interglycosidic bond in lipid A

In order to develop a generic treatment for infections with Gram- negative bacteria, we developed a synthesis of 2-acylamino-deoxynojirimycin derivatives (17, 18, 19 and 20), which will be used as haptens for raising catalytic antibodies capable of hydrol